logo

Oncosec Medical Inc (ONCS)



Trade ONCS now with
  Date
  Headline
1/21/2020 4:45:17 PM OncoSec Appoints Robert DelAversano As Principal Accounting Officer And Controller
1/21/2020 8:37:45 AM OncoSec Urges Shareholders Not To Be Distracted By Alpha's Last-Ditch Efforts To Derail CGP/Sirtex Deal
1/16/2020 8:35:28 AM OncoSec Rejects Alpha Holdings Proposal
1/14/2020 8:42:37 AM Alpha Holdings Says Makes Superior, $39.3 Mln Offer To OncoSec
12/26/2019 8:49:03 AM Alpha Says Disagree With ISS's Conclusion; Urges OncoSec Stockholders To Vote AGAINST China Grand Takeover
12/26/2019 8:31:53 AM ISS Recommends OncoSec Shareholders Vote "FOR" CGP/Sirtex Transaction
12/13/2019 8:32:43 AM OncoSec Presents Interim Data Of 28.5% Objective Response Rate From Ongoing KEYNOTE-890 Study
12/5/2019 8:47:21 AM OncoSec To Present Interim Data From KEYNOTE-890 Study Of TAVO And KEYTRUDA In Late-Stage MTNBC
11/27/2019 8:34:27 AM Alpha Wins In Nevada Court And Comments On OncoSec's Cynical Attempt To Push Through China Grand Deal
11/12/2019 8:38:40 AM OncoSec Presents Immunological Data Associated With Positive Tumor Response From TAVO KEYNOTE Studies
10/21/2019 9:03:08 AM OncoSec Provides Letter To Shareholders On Recently-Announced $30 Mln Strategic Investment
7/29/2019 8:51:08 AM Leidos Declares Quarterly Cash Dividend Of $0.34/shr, Represents $0.02 Increase; Payable Sept. 30/record Sept. 16
6/27/2019 8:38:24 AM OncoSec Gets Licensing Rights From Dana-Farber CancerInstitute To CAR T-Cell Therapies For Solid Tumor Cancers Treatment
5/29/2019 8:32:14 AM OncoSec Announces Collaboration For TAVO In Australia With Emerge Health
5/23/2019 8:33:26 AM UCSF Doses First Patient In Triple Combination Clinical Trial Of OncoSec's TAVO, Epacadostat And KEYTRUDA
5/22/2019 8:52:41 AM OncoSec Medical Prices $11 Mln Public Offering
5/21/2019 4:03:38 PM OncoSec Medical Announces Proposed Public Offering
5/20/2019 1:18:22 PM OncoSec Announces 1-for-10 Reverse Stock Split
  
 
>